The scientist’s investigation covers issues in Internal medicine, Septic shock, Immunology, Sepsis and Intensive care medicine. His work deals with themes such as Endocrinology and Resuscitation, Surgery, which intersect with Internal medicine. His Septic shock research includes elements of Mean arterial pressure, Shock and Vascular resistance.
His research integrates issues of Cell, Antibiotics and Endothelial dysfunction in his study of Immunology. His studies deal with areas such as Mortality rate and Retrospective cohort study as well as Sepsis. Many of his research projects under Intensive care medicine are closely connected to Professional practice and Medical quality with Professional practice and Medical quality, tying the diverse disciplines of science together.
Robert L. Danner mainly focuses on Internal medicine, Septic shock, Sepsis, Immunology and Intensive care medicine. The study incorporates disciplines such as Gastroenterology, Endocrinology, Antibiotics and Cardiology in addition to Internal medicine. His Septic shock research is multidisciplinary, incorporating elements of Hemodynamics, Anesthesia, Canine model and Shock.
The Sepsis study combines topics in areas such as Resuscitation and Intensive care. His Immunology research incorporates themes from Pharmacology and Pneumonia. Robert L. Danner regularly links together related areas like Clinical trial in his Intensive care medicine studies.
Robert L. Danner spends much of his time researching Internal medicine, Intensive care medicine, Sepsis, Antibiotics and Retrospective cohort study. His study looks at the relationship between Internal medicine and topics such as Clindamycin, which overlap with Propensity score matching and Streptococcus. He has included themes like Bacteremia, Severity of illness, Epidemiology and Comparative effectiveness research in his Intensive care medicine study.
His study in Septic shock and Organ dysfunction are all subfields of Sepsis. His Septic shock study introduces a deeper knowledge of Immunology. His Retrospective cohort study research integrates issues from Cohort study and MEDLINE.
His primary areas of study are Sepsis, Internal medicine, Antibiotics, Retrospective cohort study and Intensive care medicine. In his study, which falls under the umbrella issue of Sepsis, Vancomycin, Severity of illness and Antibiotic resistance is strongly linked to Epidemiology. Robert L. Danner works in the field of Internal medicine, namely Relative risk.
His Relative risk research incorporates elements of Meta-analysis, Clinical trial, Survival rate and Procalcitonin. His Antibiotics research includes themes of Odds ratio, Randomized controlled trial, Discontinuation and Drug resistance. His Intensive care medicine study incorporates themes from Mortality rate, Septic shock and Organ dysfunction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Septic Shock in Humans: Advances in the Understanding of Pathogenesis, Cardiovascular Dysfunction, and Therapy
Joseph E. Parrillo;Margaret M. Parker;Charles Natanson;Anthony F. Suffredini.
Annals of Internal Medicine (1990)
Endotoxemia in human septic shock.
Robert L. Danner;Ronald J. Elin;Jeanette M. Hosseini;Robert A. Wesley.
Chest (1991)
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.
C Natanson;P W Eichenholz;R L Danner;P Q Eichacker.
Journal of Experimental Medicine (1989)
Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014
Chanu Rhee;Chanu Rhee;Raymund Dantes;Raymund Dantes;Lauren Epstein;David J. Murphy.
JAMA (2017)
Selected Treatment Strategies for Septic Shock Based on Proposed Mechanisms of Pathogenesis
Charles Natanson;William D. Hoffman;Anthony F. Suffredini;Peter Q. Eichacker.
Annals of Internal Medicine (1994)
Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents.
G D Martich;R L Danner;M Ceska;A F Suffredini.
Journal of Experimental Medicine (1991)
Risk and the efficacy of antiinflammatory agents : retrospective and confirmatory studies of sepsis
Peter Q. Eichacker;Chantal Parent;Andre C Kalil;Claire Esposito.
American Journal of Respiratory and Critical Care Medicine (2002)
Adoptively transferred effector cells derived from naïve rather than central memory CD8+ T cells mediate superior antitumor immunity
Christian S. Hinrichs;Zachary A. Borman;Lydie Cassard;Luca Gattinoni.
Proceedings of the National Academy of Sciences of the United States of America (2009)
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
Pawel Muranski;Zachary A. Borman;Sid P. Kerkar;Christopher A. Klebanoff.
Immunity (2011)
Bundled care for septic shock: An analysis of clinical trials
Amisha V Barochia;Xizhong Cui;David Vitberg;Anthony F Suffredini.
Critical Care Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Brigham and Women's Hospital
National Institutes of Health
Center for Information Technology
National Institutes of Health
Massachusetts General Hospital
National Institutes of Health
Weill Cornell Medicine
National Institutes of Health
Thomas Jefferson University
National Institutes of Health
University of Notre Dame
Stanford University
University of Delaware
Concordia University
Chinese Academy of Sciences
University of Montpellier
Weizmann Institute of Science
King's College London
Wuhan University
University of Lorraine
University of Freiburg
University of Tsukuba
New York University
University of Newcastle Australia
Radboud University Nijmegen
Stanford University